Pre-pregnancy risk assessment and counselling of the cardiac patient
Tóm tắt
Pregnant women with heart disease often have an increased risk of maternal cardiovascular and offspring complications. The magnitude of these risks varies depending on the type and severity of the underlying disease. Therefore risk assessment should be performed before pregnancy. This can be accomplished by taking into account predictors and risk scores that have been developed in large populations of pregnant women with heart disease, as well as by consulting disease-specific pregnancy literature. A system that integrates all available knowledge about the risk of pregnancy is the adapted World Health Organisation risk classification. The safety of pregnancy for women with heart disease can be enhanced by adequate risk assessment and counselling.
Tài liệu tham khảo
Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.
Curtis SL, Marsden-Williams J, Sullivan C, et al. Current trends in the management of heart disease in pregnancy. Int J Card. 2009;133:62–9.
Schutte JM, Steggers EAP, Schuitemaker NEW, et al. The Netherlands Maternal Mortality Committee. Rise in maternal mortality in the Netherlands. BJOG. 2010;117:399–406.
Khairy P, Ouyang D, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circ. 2006;113:517–24.
Kovavisarach E, Nualplot P. Outcome of pregnancy among parturients complicated with heart disease in Rajavithi hospital. J Med As Thai. 2007;90(11):2253–9.
Song YB, Park SW, Kim JH, et al. Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci. 2008;23:808–13.
Drenthen W, Boersma E, Balci A, On behalf of the ZAHARA investigators, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.
Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Card. 2010;56:1247–53.
Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease. A literature review. J Am Coll Card. 2007;49(24):2302–11.
Balci A, Sollie KM, Mulder BJ, et al. Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Heart J. 2011 Feb;161(2):269–75.
Jastrow N, Meyer P, Khairy P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Card 2010; doi:10.1016/j.ijcard.2010.05.045.
Balci A, Sollie KW, Mulder BJ, et al. Prospective assessment of pregnancy risk estimation models in women with congenital heart disease. Eur Heart J. 2010;31(SupplI):615–6.
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J 2011; doi:10.1093/eurheartj/ehr218.
Yap SC, Drenthen W, Pieper PG, et al. On behalf of the ZAHARA INvestigators. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008;126:240-246.
Yap SC, Drenthen W, Pieper PG, et al. Outcome of Pregnancy In Women After Pulmonary Autograft Replacement For Congenital Aortic Valve Disease. J Heart Valve Dis. 2007 Jul;16(4):398–403.
Krul SP, van der Smagt JJ, van den Berg MP, et al. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail. 2011; Apr 11 (Epub ahead of print).
Thorne S, McGregor A, Nelson-Piercy C. Risk of contraception and pregnancy in heart disease. Heart. 2006;92:1520–5.